Bexsero is a vaccine indicated to protect meningococcus B - MenB, responsible for causing bacterial meningitis, in children from 2 months and adults up to 50 years of age.
Meningitis or meningococcal disease is a disease that causes symptoms such as fever, headache, nausea, vomiting, or signs of inflammation of the meninges, which most easily affect nursing babies.
How to take
The doses indicated depend on the age of each patient, and the following dosage is recommended:
- For children 2 to 5 months of age, 3 doses of the vaccine are recommended, at intervals of 2 months between doses. In addition, a booster should be done between 12 and 23 months of age;
- For children between 6 and 11 months, 2 doses are recommended at 2-month intervals between doses, and a booster should be done between 12 and 24 months of age;
- For children between 12 months and 23 years of age, 2 doses are recommended, with a 2-month interval between doses;
- For children between 2 and 10 years of age, adolescents and adults, 2 doses are recommended, with a 2-month interval between doses;
- For adolescents from 11 years of age and adults, 2 doses are recommended, with an interval of 1 month between doses.
Side effects
Some of the side effects of Bexsero in nursing babies may include changes in appetite, drowsiness, crying, convulsions, pallor, diarrhea, vomiting, fever, irritability or allergy reactions at the injection site with redness, itching, swelling or local pain.
In adolescents, the major side effects may include headache, general malaise, joint pain, nausea and pain, swelling and redness at the injection site.
Contraindications
This vaccine is contraindicated for pregnant or lactating women, children less than 2 months of age and for patients with allergy to any of the components of the formula.
